Release Date: 26/03/10 09:13 Summary: Armstrong Ellislie No1 update Price Sensitive: Yes Download Document 823.69KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%